TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
26 hedge funds and large institutions have $37.3M invested in Telesis Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
26
Holding in Top 10
1
Calls
$144K
Puts
$127K
Top Buyers
| 1 | +$145K | |
| 2 | +$98.3K | |
| 3 | +$54.3K | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$36.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$33.3K |
Top Sellers
| 1 | -$1.24M | |
| 2 | -$42.1K | |
| 3 | -$29K | |
| 4 |
Millennium Management
New York
|
-$25.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9.81K |